Business
Viveve(R) Expands in Latin America With Six New Distribution Partnerships
Viveve(R) Expands in Latin America With Six New Distribution Partnerships.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Expands in Latin America With Six New Distribution Partnerships\n\nViveve(R) Expands in Latin America With Six New Distribution Partnerships\n\n\nViveve System -- Non-surgical Treatment for Vaginal Laxity -- Now Available in 65 Countries around the World\n\nSUNNYVALE, CA--(Marketwired - July 05, 2016) - Viveve Medical, Inc. (\"Viveve\") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced six new distribution partnerships that expand commercial availability of the Viveve System to fourteen additional countries in Latin America. The new relationships provide for distribution of the Viveve System in: Argentina, Peru, Paraguay (Sirex S.A.) and Chile (Torregal), Columbia and Ecuador (Alphaeon Columbia S.A.S.), Mexico (Vitre-Tech), Panama, Costa Rica, Guatemala and Dominican Republic (Coolmed, S.A.), Uruguay (Adenor, S.A.), and Venezuela and the Caribbean (MARC Group International, LLC). \"The Latin American region represents one of the world's largest markets for aesthetic medical procedures,\" said Jim Atkinson, president and chief business officer of Viveve. \"Our collaboration with a distinguished group of distribution partners will help us to increase our presence in the region while providing outstanding service and customer support.\" Viveve now has 23 exclusive partnerships covering distribution in 65 countries around the world and has received regulatory clearance for the Viveve System in 25 of those countries thus far.\"We believe the combination of our internationally patented technology, the experience and professionalism of our partners, and the acceptance of innovative medical procedures in all of our target markets will advance Viveve's reputation as a leading provider of women's health products in this important region,\" said Patricia Scheller, chief executive officer of Viveve. \"Available safety and efficacy data continue to support the use of Viveve Treatment as a painless procedure to treat the common condition of vaginal laxity, which can profoundly impact a woman's sexual satisfaction and quality of life.\" About ViveveViveve Medical, Inc., is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the internationally patented Viveve System, is a non-surgical, ...